Skip Navigation


Cardiovascular Research Advance Access first published online on May 19, 2008
This version [Corrected Proof] published online on June 2, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn127
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
79/4/679    most recent
cvn127v2
cvn127v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Beckers, C. M.L.
Right arrow Articles by van Nieuw Amerongen, G. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckers, C. M.L.
Right arrow Articles by van Nieuw Amerongen, G. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Nuclear targeting of β-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction

Cora M.L. Beckers1, Juan J. García-Vallejo2, Victor W.M. van Hinsbergh1 and Geerten P. van Nieuw Amerongen1,*

1 Department for Physiology, VU University Medical Center, Institute for Cardiovascular Research, van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
2 Department of Molecular Cell Biology and Immunology, van der Boechorststraat 7, 1108 BH Amsterdam, The Netherlands

* Corresponding author. Tel: +31 20 4441748; fax: +31 20 4448255. E-mail address: nieuwamerongen{at}vumc.nl

Aims: Cytosolic and nuclear localization of β-catenin was observed in leaky vessels and in tumours. Several lines of evidence indicate that nuclear β-catenin facilitates angiogenesis. We hypothesized that nuclear β-catenin liberated from endothelial junctional complexes marks the transition from hyperpermeability to angiogenesis. The aim of this study was, therefore, to investigate the fate of β-catenin and the related catenin p120catenin (p120ctn), during disruption of the endothelial barrier function in human umbilical vein endothelial cells (ECs).

Methods and results: The hyperpermeability-inducer thrombin caused a Rho kinase-dependent redistribution of β-catenin from the membrane to the cytosol as evidenced by the western blot analysis of membrane and cytosol fractions and by immunohistochemistry. Glycogen synthase kinase 3β, which phosphorylates cytosolic β-catenin and thereby facilitates its proteasomal degradation, was inhibited by thrombin. The analysis of nuclear extracts demonstrated a thrombin-induced nuclear accumulation of β-catenin as well as p120ctn. Thrombin stimulation activated β-catenin-mediated transcriptional activity as evidenced by reporter assays. Finally, real-time-PCR revealed increased mRNA levels of several β-catenin target genes.

Conclusion: Thrombin induced a cytosolic stabilization of membrane-liberated β-catenin, which, together with p120ctn, subsequently translocated to the nucleus where it induces several β-catenin target genes. This supports the suggestion that membrane-liberated β-catenin and p120ctn contribute to angiogenic responses of ECs following episodes of vascular leakage.

KEYWORDS Angiogenesis; Capillary permeability; Cell communication; Signal transduction; Vasoactive agents

Time for primary review: 33 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.